Related Experiment Video

Updated: Aug 29, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

Oxidative stress in type 1 diabetes

Kathryn Haskins1, Brenda Bradley, Katherine Powers

  • 1Department of Immunology, University of Colorado Health Sciences Center, and National Jewish Medical and Research Center, Denver, Colorado 80206, USA. katie.haskins@uchsc.edu

Annals of the New York Academy of Sciences
|December 18, 2003
PubMed

Insights

Preventing oxidative stress with a superoxide dismutase (SOD) mimetic reversed macrophage defects and reduced tissue damage in a type 1 diabetes mouse model. This approach shows promise for treating type 1 diabetes complications.

Area of Science:

  • Immunology
  • Endocrinology
  • Biochemistry

Background:

  • Oxidative stress exacerbates type 1 diabetes pathogenesis and complications.
  • NOD mice exhibit heightened oxidative stress and aberrant macrophage function compared to controls.
  • Islet and vascular tissues are particularly vulnerable to oxidative damage in autoimmune diabetes.

Purpose of the Study:

  • To investigate the therapeutic potential of mitigating oxidative stress in type 1 diabetes.
  • To evaluate the impact of a superoxide dismutase (SOD) mimetic on oxidative stress and macrophage function in the NOD mouse model.

Main Methods:

  • Utilized the non-obese diabetic (NOD) mouse model for type 1 diabetes research.
  • Administered a metalloporphyrin superoxide dismutase (SOD) mimetic to prediabetic NOD mice for two weeks.
  • Assessed oxidative stress levels in islets and vascular tissues.
  • Evaluated phagocytic function and cytokine production of macrophages.

Main Results:

  • NOD mice showed significantly higher oxidative stress damage in islets and vascular tissue compared to controls.
  • Macrophages in NOD mice displayed impaired phagocytic function and altered cytokine production.
  • Treatment with the SOD mimetic markedly reduced oxidative stress in target tissues.
  • The SOD mimetic treatment reversed the observed macrophage defects.

Conclusions:

  • Targeting oxidative stress via SOD mimetics can ameliorate key pathological features of type 1 diabetes.
  • Intervention with SOD mimetics may offer a novel therapeutic strategy for managing type 1 diabetes and its vascular complications.
  • Restoration of macrophage function is a key outcome of oxidative stress reduction in this model.

More Related Videos

Analysis of Oxidative Stress in Zebrafish Embryos11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...